Your browser doesn't support javascript.
loading
Seroconversion in patients with cancer and oncology health care workers infected by SARS-CoV-2.
Marra, A; Generali, D; Zagami, P; Cervoni, V; Gandini, S; Venturini, S; Morganti, S; Passerini, R; Orecchia, R; Curigliano, G.
Affiliation
  • Marra A; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.
  • Generali D; Department of Medicine, Surgery and Health Sciences, Cattinara Hospital, University of Trieste, Trieste, Italy; U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale, Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy.
  • Zagami P; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.
  • Cervoni V; U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale, Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy.
  • Gandini S; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Venturini S; Department of Management, University of Turin, Turin, Italy; Centre for Research on Health and Social Care Management (CeRGAS), SDA Bocconi School of Management, Milan, Italy.
  • Morganti S; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.
  • Passerini R; Division of Laboratory Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Orecchia R; Scientific Direction, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Curigliano G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
Ann Oncol ; 32(1): 113-119, 2021 01.
Article in En | MEDLINE | ID: mdl-33098994
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Qualitative_research / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Qualitative_research / Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article